JadadA.R., CarrollD., GlynnC.J., MooreR.A., McQuayH.Morphine responsiveness of chronic pain: Double blind randomised crossover with patient controlled analgesia.Lancet1992; 339: 1367–1371.
2.
TanelianD.L., BroseW.G.Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lignocaine, carbamazepine and mexiletine.Anesthesiology1991; 74: 949–951.
3.
McQuayH., CarollD., GlynnC.Low dose amitryptiline in the treatment of chronic pain.Anaesthesia1992; 47: 646–652.
4.
SjobergM., AppelgrenL., EinarssonS.Long-term intrathecal morphine and bupivacaine in “refractory” cancer pain.Acta Anaesthesiol Scand1991; 35: 30–43.
5.
CrulR.I.P., DelhaasE.M.Technical complications during long term subarachnoid or epidural administration of morphine in terminally ill cancer patients.Anesth1991; 16: 209–213.
6.
KroinJ.S., McCarthyR.J., PennR.D., KernsJ.M., IvankovichA.D.The effect of chronic subarachnoid bupivacaine infusion in dogs.Anesthesiology1987; 66: 737–742.
7.
SjobergM., KarlssonP.A., NordborgC.Neuropathologic findings after longer term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients.Anesthesiology1992; 76: 173–186.
8.
NorthR.B., CutchisP.N., EpsteinJ.A., LongD.M.Spinal cord compression complicating subarachnoid infusion of morphine: Case report and laboratory experience.Neurosurg1991; 29: 778–784.
LipmanJ.J., BlumenkopffB.Comparison of subjective and objective analgesic effects of intravenous and intrathecal morphine in chronic pain patients by heat beam dolorimetry.Pain1989; 39: 249–256.